Refametinib (R) 0531 noncardiotoxic aza-anthracenedione analogue with potential

noncardiotoxic aza-anthracenedione analogue with potential antineoplastic activity

C[C@@H](NC(=O)[C@@H]1CCCN1C(=O)[C@H](CCCCNC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CC1C=CC(=CC=1)NC(N)=O)NC(=O)[C@H](CC1C=CC(=CC=1)NC(=O)[C@@H]1CC(=O)NC(=O)N1)NC(=O)[C@H](CO)NC(=O)[C@@H](CC1=CN=CC=C1)NC(=O)[C@@H](CC1C=CC(Cl)=CC=1)NC(=O)[C@@H](CC1=CC2=CC=CC=C2C=C1)NC(C)=O)C(N)=O

for the first time to our knowledge

and in steroid-resistant nephrotic syndrome

Chemical Name: 2-methyl-6-(2-phenylethynyl)pyridine

Refametinib (R) 0531 noncardiotoxic aza-anthracenedione analogue with potentialRefametinib R enantiomer is a potent, selective and allosteric inhibitor of MEK1 2 in enzyme inhibition assays. Refametinib R has been reported to inhibit MEK activity and inhibit anchorage dependent growth. Moreover, it has shown a potent tumor growth inhibition (TGI) in the human A375 and colon carcinoma Colo205 tumor xenograft models. Product information CAS Number: 923032 38 6 Molecular Weight: 572. 34 Formula: C19H20F3IN2O5S Synonym: BAY 869766 R